Selective androgen receptor modulators for treating diabetes
AssigneeUniversity of Tennessee Research Foundation
InventorsJames T. Dalton, Duane D. Miller
Life of this patent
Estimating the term…
Abstract
This invention provides use of a SARM compound or a composition comprising the same in treating a variety of diseases or conditions in a subject, including, inter-alia, a diabetes disease, and/or disorder such as cardiovascular disease, atherosclerosis, cerebrovascular conditions, diabetic nephropathy, diabetic neuropathy and diabetic retinopathy.
Claims5
A method of reducing the severity of, reducing the incidence of, or reducing pathogenesis of diabetes in a human subject, comprising the step of administering to said subject, a therapeutically effective amount of a selective androgen receptor modulator (SARM) compound of formula III:
A method of reducing the severity of, reducing the incidence of, or reducing pathogenesis of diabetes in a human subject, comprising the step of administering to said subject, a therapeutically effective amount of a selective androgen receptor modulator (SARM) compound of formula III:
- wherein said compound is its isomer, pharmaceutically acceptable salt, N-oxide, or any combination thereof.
A method of reducing the severity of, reducing the incidence of, or reducing pathogenesis of diabetes in a human subject, comprising the step of administering to said subject, a therapeutically effective amount of a selective androgen receptor modulator (SARM) compound of formula III:
- wherein said administering comprises administering a pharmaceutical composition comprising said compound;
- and a pharmaceutically acceptable carrier, and wherein said compound is its isomer, pharmaceutically acceptable salt, N-oxide, or any combination thereof.
Dependencies are inferred from the claim text.